MagForce AG Supports Brain Cancer Patient Event Of University Hospital Münster In The Run-Up To World Brain Tumor Day 2016

BERLIN & Nevada--(BUSINESS WIRE)--MagForce AG (Frankfurt, Entry Standard, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, today announced that the Company is participating in the event for brain cancer patients and their relatives which will be hosted by the Brain Tumor Center of University Hospital Münster on May 27, 2016 in the run-up to World Brain Tumor Day.